- Launched new primary care practice and navigation program to serve the Asian American community in New Jersey - Work with Asian community organization through health fairs and other collaborations to bring awareness and health education to the population - Build network of physicians and services in the SBMC network to serve growing Asian population- Internal Medicine Clinician - Primary care provider for Barnabas Health Medical Group in the Center for Asian Health - 2004- Received CDC grant for Hepatitis B awareness, screening and education in foreign-born community in Northern New Jersey and NYC - Provide education and screening events to the community - Provide linkage to care for hepatitis B patientshttp://www.cdc.gov/hepatitis/Partners/CommunityBasedHepBProgs.htm- Directed hospital based Viral Hepatitis screening with linkage-to-care and primary care based Hep B and Hep C care and treatment.- Launched the SBMC Liver Center connecting service lines within hospital and to University Hospital liver transplant center.

Internal Medicine ClinicianHepatitis B Program Director• Direct the center's hepatitis B activities, including clinical care, community outreach & screening and research. • Implemented Chronic Care Model for hepatitis B patients (3000 active patients), receiving national attention for our work.• Spearheaded innovative care strategies (web-based provider/specialist conferencing, EMR-based provider tools)• Collaborate with CDC, HRSA and other federal agencies on hepatitis B models; presenting nationally on our work • Led creation of Hepatitis B Moms Program, coordinating care of pregnant HBV mothers and their infants• Responsible for grant writing and reporting of Hepatitis B grants, working with multiple funders• Conduct various forms of media coverage (e.g.,TV/radio interviews, press conferencesMeaningful Use TeamCoordinate clinical and EMR-based changes for health center to meet Meaningful Use requirements

Post marketing surveillance of human cell and tissue transplants.• Conducted safety surveillance of Human Cells and Tissue Transplants (HCT/Ps)• Monitored and investigated MedWatch reports on transplant related infections, coordinating follow-up with clinicians, government agencies and manufacturers and reporting data• Developed policies for new regulation of HCT/Ps which went into place May 2005• Developed FDA guidance for industry and policies for adverse event investigation (HCT/P)• Coordinated a large multi-state FDA and CDC outbreak investigation following a breach of tissue harvesting protocol